GlaxoSmithKline Q4 net dips 6 pc to Rs 105 cr

Last Updated : May 24 2018 | 7:30 PM IST

GlaxoSmithKline Pharmaceuticals today reported 6.35 per cent dip in standalone net profit to Rs 105.55 crore for the quarter ended March 31, 2018.

The company had posted a net profit of Rs 112.71 crore for the same period of 2016-17, GlaxoSmithKline said in a filing to BSE.

Standalone total income stood at Rs 766.92 crore for the quarter under review as against Rs 798.82 crore in the year-ago period.

For 2017-18, the company posted a net profit of Rs 351.98 crore as against Rs 336.78 crore in the previous year.

Total income in 2017-18 stood at Rs 2,949.40 crore. It was Rs 3,066.52 crore in the preceding year.

In a separate filing, the company said its board has recommended a dividend of Rs 35 per equity share of face value of Rs 10 each for 2017-18.

Company's stock today closed at Rs 2,388.90 on BSE, down 0.64 per cent from previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Already subscribed? Log in

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

3 Months

₹300/Month

SAVE 25%

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

SAVE 25%